Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new excimer laser technology ➤ Phase 3 trial to evaluate phentolamine for treatment of decreased visual acuity ➤ Phase 2 trial of investigational dry eye drug sees effect on signs and symptoms ➤ Study has new findings to promote corneal healing ➤ ASCRS news and events
The rotational stability of toric IOLs and reposition rates have been well studied and reported. In most cases, any rotation that occurs postop is usually 5 degrees off axis or less. Four ophthalmologists shared their thoughts on the prevention and management of this issue.
Karolinne Rocha, MD, PhD, considered lessons she has learned and previewed the articles in this issue’s Refractive section.
Many surgeons have now gained experience with the EVO ICL (STAAR Surgical), which was FDA approved in April 2022. Several spoke to EyeWorld about what they’ve learned from using it in practice.
➤ World’s first whole-eye transplant ➤ Regenerative Medicine Advanced Therapy designation for investigational therapy for Leber congenital amaurosis ➤ 48-month trial data for retinal prosthesis for patients with severe atrophic AMD ➤ First patient dosed in Phase 1/2 trial for Stargardt disease gene therapy ➤ Partnership to develop molecule targeting DME ➤ ASCRS news and events
➤ Editorial statement on the nomenclature for refractive lenticule extraction procedure ➤ First patient dosed in Phase 1/2 trial evaluating allogenic cell therapy for corneal edema ➤ IND granted to company investigating therapy for geographic atrophy ➤ Licensing agreement to develop neuroprotective drug ➤ Retinal imaging test detects increased risk for type of dementia ➤ ASCRS news and events
The IC-8 Apthera IOL (Bausch + Lomb) is now available in the U.S., and several surgeons discussed how this technology fits in to their practice and for which patients.
Karolinne Maia Rocha, MD, PhD, Refractive Editor, let readers know what they can expect in the Refractive section of the issue and shared some of the research she has been doing on the IC-8 Apthera.
➤ FDA issues eight warning letters ➤ Positive Phase 2 safety update for investigational treatment of retinal diseases ➤ First-in-human titratable glaucoma therapy system ➤ Companies partner to develop biological dry eye treatment ➤ Geographic atrophy drug development discontinued ➤ ASCRS news and events
A patient who elected years ago to have refractive surgery is no longer seeing as well and learns they have ectasia. In many cases their vision can be preserved and/or improved. EyeWorld spoke with three ophthalmologists about how they address corneal and refractive issues for these patients.